Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014 (2014), Article ID 213790, 9 pages
http://dx.doi.org/10.1155/2014/213790
Research Article

Polymorphism of XRCC1, XRCC3, and XPD Genes and Risk of Chronic Myeloid Leukemia

1Department of Medical Genetics, University of Medicine and Pharmacy Tirgu Mures, 38 Gh, Marinescu Street, Romania
2Department of Medical Genetics, “Iuliu Hatieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania
3Hematology Clinic 1, University of Medicine and Pharmacy Tirgu Mures, Romania
4Hematology Clinic 2, University of Medicine and Pharmacy Tirgu Mures, Romania
5Department of Hematology, “Ion Chiricuta” Cancer Institute, Cluj-Napoca, Romania
6Pediatric Clinic, University of Medicine and Pharmacy Tirgu Mures, Romania
7Laboratory Medicine, University of Medicine and Pharmacy Tirgu Mures, Romania

Received 28 February 2014; Revised 22 April 2014; Accepted 28 April 2014; Published 15 May 2014

Academic Editor: Paul W. Doetsch

Copyright © 2014 Claudia Bănescu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Jabbour and H. Kantarjian, “Chronic myeloid leukemia: 2012 update on diagnosis, monitoring, and management,” The American Journal of Hematology, vol. 87, no. 11, pp. 1037–1045, 2012. View at Publisher · View at Google Scholar
  2. A. Sallmyr, J. Fan, and F. V. Rassool, “Genomic instability in myeloid malignancies: increased reactive oxygen species (ROS), DNA double strand breaks (DSBs) and error-prone repair,” Cancer Letters, vol. 270, no. 1, pp. 1–9, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. A. D. D'Andrea, “Targeting DNA repair pathways in AML,” Best Practice and Research: Clinical Haematology, vol. 23, no. 4, pp. 469–473, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Ronen and B. W. Glickman, “Human DNA repair genes,” Environmental and Molecular Mutagenesis, vol. 37, no. 3, pp. 241–283, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. E. Braithwaite, X. Wu, and Z. Wang, “Repair of DNA lesions: mechanisms and relative repair efficiencies,” Mutation Research—Fundamental and Molecular Mechanisms of Mutagenesis, vol. 424, no. 1-2, pp. 207–219, 1999. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Rollinson, A. G. Smith, J. M. Allan et al., “RAD51 homologous recombination repair gene haplotypes and risk of acute myeloid leukaemia,” Leukemia Research, vol. 31, no. 2, pp. 169–174, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Lindahl and R. D. Wood, “Quality control by DNA repair,” Science, vol. 286, no. 5446, pp. 1897–1905, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. R. J. Hung, J. Hall, P. Brennan, and P. Boffetta, “Genetic polymorphisms in the base excision repair pathway and cancer risk: a huge review,” The American Journal of Epidemiology, vol. 162, no. 10, pp. 925–942, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Batar, M. Güven, S. Bariş, T. Celkan, and I. Yildiz, “DNA repair gene XPD and XRCC1 polymorphisms and the risk of childhood acute lymphoblastic leukemia,” Leukemia Research, vol. 33, no. 6, pp. 759–763, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Bănescu, C. Duicu, A. P. Trifa, and M. Dobreanu, “XRCC1 Arg194Trp and Arg399Gln polymorphisms are significantly associated with shorter survival in acute myeloid leukemia,” Leukemia and Lymphoma, vol. 55, no. 2, pp. 365–370, 2014. View at Publisher · View at Google Scholar
  11. J. Du, C. Lu, G. Cui, Y. Chen, and J. He, “DNA repair gene XRCC1 polymorphisms and susceptibility to childhood acute lymphoblastic leukemia: a meta-analysis,” Chinese Journal of Cancer Research, vol. 25, no. 4, pp. 405–415, 2013. View at Google Scholar
  12. R. Wang, X. Hu, Y. Zhou et al., “XRCC1 Arg399Gln and Arg194Trp polymorphisms in childhood acute lymphoblastic leukemia risk: a meta-analysis,” Leukemia and Lymphoma, vol. 54, no. 1, pp. 153–159, 2013. View at Publisher · View at Google Scholar
  13. M. S. El-Din, H. Raslan, S. Abdel-Hamid, and M. Makhlouf, “Detection of XRCC1 gene polymorphisms in Egyptian patients with acute myeloid leukemia,” Comparative Clinical Pathology, vol. 21, no. 5, pp. 505–513, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Annamaneni, M. Gorre, S. Kagita et al., “Association of XRCC1 gene polymorphisms with chronic myeloid leukemia in the population of Andhra Pradesh, India,” Hematology, vol. 18, no. 3, pp. 163–168, 2013. View at Publisher · View at Google Scholar
  15. N. Kuptsova, K. J. Kopecky, J. Godwin et al., “Polymorphisms in DNA repair genes and therapeutic outcomes of AML patients from SWOG clinical trials,” Blood, vol. 109, no. 9, pp. 3936–3944, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Seedhouse and N. Russell, “Advances in the understanding of susceptibility to treatment-related acute myeloid leukaemia,” The British Journal of Haematology, vol. 137, no. 6, pp. 513–529, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Joseph, P. Kusumakumary, P. Chacko, A. Abraham, and M. R. Pillai, “DNA repair gene XRCC1 polymorphisms in childhood acute lymphoblastic leukemia,” Cancer Letters, vol. 217, no. 1, pp. 17–24, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Pakakasama, T. Sirirat, S. Kanchanachumpol et al., “Genetic polymorphisms and haplotypes of DNA repair genes in childhood acute lymphoblastic leukemia,” Pediatric Blood and Cancer, vol. 48, no. 1, pp. 16–20, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. J. P. Meza-Espinoza, V. Peralta-Leal, M. Gutierrez-Angulo et al., “XRCC1 polymorphisms and haplotypes in Mexican patients with acute lymphoblastic leukemia,” Genetics and Molecular Research, vol. 8, no. 4, pp. 1451–1458, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Ganster, J. Neesen, S. Zehetmayer et al., “DNA repair polymorphisms associated with cytogenetic subgroups in B-cell chronic lymphocytic leukemia,” Genes Chromosomes and Cancer, vol. 48, no. 9, pp. 760–767, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. N. Duman, M. Aktan, S. Ozturk et al., “Investigation of Arg399Gln and Arg194Trp polymorphisms of the XRCC1 (X-ray cross-complementing group 1) gene and its correlation to sister chromatid exchange frequency in patients with chronic lymphocytic leukemia,” Genetic Testing and Molecular Biomarkers, vol. 16, no. 4, pp. 287–291, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Liu, B. Song, Z. Wang et al., “DNA repair gene XRCC1 polymorphisms and non-Hodgkin lymphoma risk in a Chinese population,” Cancer Genetics and Cytogenetics, vol. 191, no. 2, pp. 67–72, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. K. E. Smedby, C. M. Lindgren, H. Hjalgrim et al., “Variation in DNA repair genes ERCC2, XRCC1, and XRCC3 and risk of follicular lymphoma,” Cancer Epidemiology Biomarkers and Prevention, vol. 15, no. 2, pp. 258–265, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. R. El-Zein, C. M. Monroy, C. J. Etzel et al., “Genetic polymorphisms in DNA repair genes as modulators of hodgkin disease risk,” Cancer, vol. 115, no. 8, pp. 1651–1659, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Shen, M. P. Purdue, A. Kricker et al., “Polymorphisms in DNA repair genes and risk of non-Hodgkin's lymphoma in New South Wales, Australia,” Haematologica, vol. 92, no. 9, pp. 1180–1185, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Matsuo, N. Hamajima, R. Suzuki et al., “Lack of association between DNA base excision repair gene XRCC1 Gln399Arg polymorphism and risk of malignant lymphoma in Japan,” Cancer Genetics and Cytogenetics, vol. 149, no. 1, pp. 77–80, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. U. Deligezer, E. E. Akisik, and N. Dalay, “Lack of association of XRCC1 codon 399Gln polymorphism with chronic myelogenous leukemia,” Anticancer Research, vol. 27, no. 4, pp. 2453–2456, 2007. View at Google Scholar · View at Scopus
  28. L. M. Procopciuc and G. Osian, “Interaction between lifestyle factors and the XRCC1, XPD, and XRCC3 genetic variations modulates the risk for sporadic colorectal cancer,” Revista Română de Medicină de Laborator, vol. 22, no. 1, pp. 129–141, 2014. View at Publisher · View at Google Scholar
  29. Y. Yan, H. Liang, T. Li et al., “Association of XRCC3 Thr241Met polymorphisms and leukemia risk: evidence from a meta-analysis,” Leukemia and Lymphoma, 2014. View at Publisher · View at Google Scholar
  30. L. Qin, X. Chen, P. Li, Z. Yang, and W. Mo, “Comprehensive assessment of the association between DNA repair gene XRCC3 Thr241Met polymorphism and leukemia risk,” Tumor Biology, vol. 35, no. 3, pp. 2521–2528, 2014. View at Publisher · View at Google Scholar
  31. C. Seedhouse, R. Faulkner, N. Ashraf, E. Das-Gupta, and N. Russell, “Polymorphisms in genes involved in homologous recombination repair interact to increase the risk of developing acute myeloid leukemia,” Clinical Cancer Research, vol. 10, no. 8, pp. 2675–2680, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Catana, R. A. Popp, M. Pop, M. D. Porojan, F. M. Petrisor, and I. V. Pop, “Genetic polymorphism of DNA repair gene ERCC2/XPD (Arg 156 Arg) (A22541C) and lung cancer risk in Northern Romania,” Revista Română de Medicină de Laborator, vol. 20, no. 2, pp. 157–161, 2012. View at Google Scholar
  33. S. Benhamou and A. Sarasin, “ERCC2/XPD gene polymorphisms and cancer risk,” Mutagenesis, vol. 17, no. 6, pp. 463–469, 2002. View at Google Scholar · View at Scopus
  34. C. C. Yeh, F. C. Sung, R. Tang, C. R. Chang-Chieh, and L. L. Hsieh, “Polymorphisms of the XRCC1, XRCC3, and XPD genes, and colorectal cancer risk: a case-control study in Taiwan,” BMC Cancer, vol. 5, article 12, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Sorour, M. W. Ayad, and H. Kassem, “The genotype distribution of the XRCC1, XRCC3, and XPD DNA repair genes and their role for the development of acute myeloblastic leukemia,” Genetic Testing and Molecular Biomarkers, vol. 17, no. 3, pp. 195–201, 2013. View at Publisher · View at Google Scholar
  36. A. Özcan, M. Pehlivan, A. G. Tomatir et al., “Polymorphisms of the DNA repair gene XPD (751) and XRCC1 (399) correlates with risk of hematological malignancies in Turkish population,” African Journal of Biotechnology, vol. 10, no. 44, pp. 8860–8870, 2011. View at Google Scholar · View at Scopus
  37. J. Y. Shi, Z. H. Ren, B. Jiao et al., “Genetic variations of DNA repair genes and their prognostic significance in patients with acute myeloid leukemia,” International Journal of Cancer, vol. 128, no. 1, pp. 233–238, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. F. Wang, D. Chang, F. Hu et al., “DNA repair gene XPD polymorphisms and cancer risk: a meta-analysis based on 56 case-control studies,” Cancer Epidemiology Biomarkers and Prevention, vol. 17, no. 3, pp. 507–517, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. J. M. Allan, A. G. Smith, K. Wheatley et al., “Genetic variation in XPD predicts treatment outcome and risk of acute myeloid leukemia following chemotherapy,” Blood, vol. 104, no. 13, pp. 3872–3877, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. P. A. Mehta, T. A. Alonzo, R. B. Gerbing et al., “XPD Lys751Gln polymorphism in the etiology and outcome of childhood acute myeloid leukemia: a children's oncology group report,” Blood, vol. 107, no. 1, pp. 39–45, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. C. Seedhouse, R. Bainton, M. Lewis, A. Harding, N. Russell, and E. Das-Gupta, “The genotype distribution of the XRCC1 gene indicates a role for base excision repair in the development of therapy-related acute myeloblastic leukemia,” Blood, vol. 100, no. 10, pp. 3761–3766, 2002. View at Publisher · View at Google Scholar · View at Scopus
  42. A. K. Mitra, N. Singh, V. K. Garg, R. Chaturvedi, M. Sharma, and S. K. Rath, “Statistically significant association of the single nucleotide polymorphism (SNP) rs13181 (ERCC2) with predisposition to squamous cell carcinomas of the head and neck (SCCHN) and breast cancer in the north Indian population,” Journal of Experimental and Clinical Cancer Research, vol. 28, no. 1, article 104, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. A. Tefferi and J. W. Vardiman, “Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms,” Leukemia, vol. 22, no. 1, pp. 14–22, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. J. W. Vardiman, J. Thiele, D. A. Arber et al., “The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes,” Blood, vol. 114, no. 5, pp. 937–951, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. Q. Wang, A. H. Wang, H. S. Tan et al., “Genetic polymorphisms of DNA repair genes and chromosomal damage in workers exposed to 1,3-butadiene,” Carcinogenesis, vol. 31, no. 5, pp. 858–863, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. G. Matullo, D. Palli, M. Peluso et al., “XRCC1, XRCC3, XPD gene polymorphisms, smoking and 32P-DNA adducts in a sample of healthy subjects,” Carcinogenesis, vol. 22, no. 9, pp. 1437–1445, 2001. View at Google Scholar · View at Scopus
  47. http://www.arcrareromania.ro/lmc2013.
  48. T. Takanami, J. Nakamura, Y. Kubota, and S. Horiuchi, “The Arg280His polymorphism in X-ray repair cross-complementing gene 1 impairs DNA repair ability,” Mutation Research—Genetic Toxicology and Environmental Mutagenesis, vol. 582, no. 1-2, pp. 135–145, 2005. View at Publisher · View at Google Scholar · View at Scopus
  49. H. Zhang, H. Liu, and G. Jiang, “Genetic polymorphisms of XRCC1 and leukemia risk: a meta-analysis of 19 case-control studies,” PLoS ONE, vol. 8, no. 11, Article ID e80687, 2013. View at Publisher · View at Google Scholar
  50. Y. Yan, H. Liang, R. Li et al., “XRCC3 Thr241Met polymorphism and ovarian cancer risk: a meta-analysis,” Tumor Biology, vol. 35, no. 3, pp. 2711–2715, 2014. View at Publisher · View at Google Scholar
  51. M. T. Voso, E. Fabiani, F. D'Alo' et al., “Increased risk of acute myeloid leukaemia due to polymorphisms in detoxification and DNA repair enzymes,” Annals of Oncology, vol. 18, no. 9, pp. 1523–1528, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. M. S. Hamdy, A. M. El-Haddad, N. M. B. El-Din, M. M. Makhlouf, and S. M. Abdel-Hamid, “RAD51 and XRCC3 gene polymorphisms and the risk of developing acute myeloid leukemia,” Journal of Investigative Medicine, vol. 59, no. 7, pp. 1124–1130, 2011. View at Publisher · View at Google Scholar · View at Scopus